 |
 |
 |
 |
 |
 |
The SGC is engaged in pre-competitive research to facilitate the discovery of new medicines. As part of its mission the SGC is generating reagents and knowledge related to human proteins and proteins from human parasites. The SGC believes that its output will have maximal benefit if released into the public domain without restriction on use, and thus has adopted the following Open Access policy.
The SGC and its scientists are committed to making their research outputs (materials and knowledge) available without restriction on use. This means that the SGC will promptly place its results in the public domain and will not agree to file for patent protection on any of its research outputs. It will seek the same commitment from any research collaborator.
- Edwards, A.M. Bermuda Principles meet structural biology. Nature Structural and Molecular Biology 15:116 (2008)
- Edwards A.M. Open-source science to enable drug discovery. Drug Discovery Today 13:731 (2008)
- Edwards, A.M., Bountra, C., Kerr, D.J. and Willson T.M. Open access chemical and clinical probes to support drug discovery. Nature Chemical Biology 5:436 (2009)
- Weigelt, J. The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery. EMBO Rep. 10:941 (2009).